|Bid||2.9600 x 1100|
|Ask||199,999.9844 x 1300|
|Day's Range||3.1454 - 3.1454|
|52 Week Range||2.0300 - 6.6400|
|Beta (3Y Monthly)||1.21|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 12, 2018 - Nov 16, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.55|
NEW YORK, Nov. 19, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
ProPhase Labs Inc (NASDAQ:PRPH), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is PRPH Read More...
DOYLESTOWN, Pennsylvania, Nov. 14, 2018 -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported its financial results for the three and nine months ended.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 20) Avanos Medical Inc (NYSE: AVNS ) Becton Dickinson and Co (NYSE: ...
After looking at ProPhase Labs Inc’s (NASDAQ:PRPH) latest earnings announcement (31 March 2018), I found it useful to revisit the company’s performance in the past couple of years and assessRead More...
NEW YORK, NY / ACCESSWIRE / March 21, 2018 / ProPhase Labs, Inc. (NASDAQ: PRPH ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 21, 2018 at 11:00 AM Eastern Time. ...